1. Differential effects of vildagliptin and glimepiride on glucose fluctuations in patients with type 2 diabetes mellitus assessed using continuous glucose monitoring. Issue 12 (14th July 2013) Authors: He, Y. L.; Foteinos, G.; Neelakantham, S.; Mattapalli, D.; Kulmatycki, K.; Forst, T.; Taylor, A. Journal: Diabetes, obesity & metabolism Issue: Volume 15:Issue 12(2013:Dec.) Page Start: 1111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effect of vildagliptin compared to glimepiride on postprandial proinsulin processing in the β cell of patients with type 2 diabetes mellitus. Issue 6 (6th February 2013) Authors: Forst, T.; Dworak, M.; Berndt‐Zipfel, C.; Löffler, A.; Klamp, I.; Mitry, M.; Pfützner, A. Journal: Diabetes, obesity & metabolism Issue: Volume 15:Issue 6(2013:Jun.) Page Start: 576 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Pharmacodynamic characteristics of lixisenatide once daily versus liraglutide once daily in patients with type 2 diabetes insufficiently controlled on metformin. Issue 7 (25th February 2013) Authors: Kapitza, C.; Forst, T.; Coester, H.‐V.; Poitiers, F.; Ruus, P.; Hincelin‐Méry, A. Journal: Diabetes, obesity & metabolism Issue: Volume 15:Issue 7(2013:Jul.) Page Start: 642 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗